Revenue from Contract with Customer, Excluding Assessed Tax in USD of Vitro Biopharma, Inc. from Q4 2021 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and change rate from Q4 2021 to Q2 2025.
- Vitro Biopharma, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 31 Jul 2025 was $609K, a 90.3% increase year-over-year.
- Vitro Biopharma, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending 31 Jul 2025 was $2.11M, a 13.9% increase year-over-year.
- Vitro Biopharma, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $1.86M, a 5.23% increase from 2023.
- Vitro Biopharma, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $1.76M, a 46.5% decline from 2022.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)